Skip to content

AFib to Affect Nearly 12 Million Americans by 2030

AFib's prevalence is rising fast. Learn about its risks and how to manage it.

In the picture I can see dial gauge of a wrist watch.
In the picture I can see dial gauge of a wrist watch.

AFib to Affect Nearly 12 Million Americans by 2030

Atrial fibrillation, the most common heart arrhythmia, affects the heart's rhythm and blood flow, posing a significant risk of blood clots and stroke. The Centers for Disease Control and Prevention (CDC) projects that nearly 12 million Americans will have AFib by 2030.

AFib occurs when the heart's upper chambers beat irregularly, disrupting blood flow to the lower chambers and the rest of the body. Symptoms can include heart palpitations, chest pain, fatigue, shortness of breath, and weakness, but some people may not experience any. If left untreated, AFib can be deadly. Treatments involve medications to manage heart rate and rhythm, along with lifestyle changes like a heart-healthy diet and regular exercise. Medications include anticoagulants, with oral options like warfarin, apixaban, rivaroxaban, and dabigatran, and injectable heparin. The average heart rate for adults is between 60 and 100 beats per minute; any significant deviation may indicate an irregular heartbeat.

Atrial fibrillation is a serious condition that requires medical attention. With proper care, including medication and lifestyle changes, individuals with AFib can lead normal, active lives. As the prevalence of AFib is set to rise in the coming years, understanding its symptoms and risks is crucial for early detection and management.

Read also:

Latest